<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00843180</url>
  </required_header>
  <id_info>
    <org_study_id>H41337-33343</org_study_id>
    <nct_id>NCT00843180</nct_id>
  </id_info>
  <brief_title>Massage for Pediatric Oncology</brief_title>
  <official_title>Massage for Children Undergoing Bone Marrow Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Undergoing bone marrow transplantation (BMT) is associated with a high level of distress for
      patients and caregivers. Clinical research studies have reported benefits from massage for a)
      oncology patients, b) children, c) adults and children undergoing bone marrow transplants. A
      multi-center study of an intervention using a combination of massage therapy and a laugh cart
      to reduce distress in pediatric oncology patients undergoing BMT (PI: Phipps) is completed
      with results not yet published. There is still a need for independent studies to isolate the
      effect of massage for clinical outcomes (such as improved nausea and pain control) in
      children. Furthermore, this study will test the acceptability of an augmented massage
      intervention. In addition to provider-child massage, the augmented massage intervention
      includes training of the resident parent to provide additional parent-child massage, to
      relieve symptoms as needed. The goal of this augmented intervention is the improvement of
      symptom management in patients and decreased stress and feelings of helplessness in parents.

      We propose a randomized pilot study at the UCSF pediatric bone marrow transplant center to
      assess the feasibility of a higher-quality study of the effects of massage in this
      population.

      Aim 1: Determine the acceptability of a massage intervention for patients and parents on a
      pediatric bone marrow transplant unit.

      Aim 2: Explore the logistics of implementing the augmented massage intervention at the
      bedside offered to consecutive patients over one year's time.

      Aim 3: Collect preliminary data for patients and parents including patient clinical outcomes,
      quality of life, and satisfaction, and parental stress and mood to allow sample size
      calculations for further studies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a pilot randomized controlled feasibility trial of an augmented massage
      intervention, compared to a usual-care control group, in which intervention group
      participants will receive up to 3 massage sessions per week, during the 4-6 hospitalization
      at UCSF for Bone Marrow Transplant (BMT).

      Participants will be approximately 24 children recruited from consecutive sample of pediatric
      cancer and non-cancer patients undergoing BMT age 5 to 18 admitted to UCSF children's
      hospital during one calendar year.

      Intervention: Massage sessions will be gentle Swedish style combine with acupressure and will
      range from 20-45 minutes, provided by credentialed and trained massage therapists;
      augmentation will involve massage training for the resident parent, who rooms with the
      patient, to administer massage to his/her child during the course of the hospital stay. The
      control group will receive standard-care.

      We will collect feasibility data and do exploratory comparison of clinical outcomes between
      groups.

      Knowledge to be gained: We will have preliminary data for a larger trial that will determine
      whether an augmented massage intervention can support symptom management in the pediatric BMT
      unit.

      B. Hypothesis(es): Briefly explain the hypothesis(es) to be tested. If the study is not
      designed to test a hypothesis, simply state &quot;None.&quot; Hypothesis 1a: &gt;60% of Patients are
      willing to be randomized to the massage study.

      Hypothesis 1b: 80% of patients randomized to massage will accept the massage intervention
      when offered.

      Hypothesis 1c: The majority of parents (&gt;60%) are willing to learn massage techniques for use
      on their children.

      Hypothesis 2a: Professional massage providers will be able to deliver massage, negotiating
      schedule, space, time, and other patient-related medical activities and will be able to
      schedule &gt;50% of planned massages.

      Hypothesis 2b: Massage providers will be able to assess the acceptable time period for
      massage (between 10 minutes and 45 minutes).

      Hypothesis 2c: Parents will carry out the massage on their children, will do at least 5
      massages over the study period and are willing to provide a self-report of estimated time
      engaged in massage.

      Hypothesis 3a: 80% of patients will answer survey questions about their experience in general
      and the massage intervention.

      Hypothesis 3b: The RA will be able to collect clinical data from chart review and
      electronically stored lab data .

      Hypothesis 3c: 80% of parents will answer survey questions about their experience in learning
      and delivering massage, stress, mood, PTSD symptoms and self-efficacy around patient
      management.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Days With Pain Scores &gt;3 Measured on Numeric Rating Scale (Range 0-10; 0 for no Pain; 10 for Worst Pain Imaginable)</measure>
    <time_frame>7 days pre to 21 days post transplant = 28 days</time_frame>
    <description>days of pain &gt;3 by nurses notes based on pain scores on numeric rating scale (up to 28 days)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Vomiting Episodes</measure>
    <time_frame>day -7 to +21 around transplant date</time_frame>
    <description>number of vomiting episodes as reported by nurses per occurence (no upper limit)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of Hospital Stay</measure>
    <time_frame>days of hospital stay after bone marrow transplant</time_frame>
    <description>days of hospital stay after bone marrow transplant (up to 100 days; participant observation was censored after 100 days)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days to Recovery Neutrophil Count</measure>
    <time_frame>hospital stay</time_frame>
    <description>number of days to recovery neutrophil count &gt;500 cells per microliter for 2 consecutive days (range, up to 100 days, censored at 100 days)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Bone Marrow Transplantation</condition>
  <condition>Distress</condition>
  <arm_group>
    <arm_group_label>massage</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>usual care only as control arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>massage</intervention_name>
    <description>one to three massages per week by massage practitioner additional massages by resident parent who is being taught to massage her/his child</description>
    <arm_group_label>massage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Being 5 to 18 years old

          -  Admitted for BMT.

        Rationale: This is a pediatric study for children up to age 18 admitted to the BMT unit.
        Questionnaires are not designed for children under age 5.

        Exclusion Criteria:

          -  Parent or child unable to answer questionnaire due to language limitations.

        Rationale: The pilot character of the study with its limited budget does not include
        instruments in foreign languages, such as Chinese or Spanish. This could be a project for
        further studies.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wolf E Mehling, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Childrens' Hospital UCSF</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2009</study_first_submitted>
  <study_first_submitted_qc>February 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2009</study_first_posted>
  <results_first_submitted>February 7, 2012</results_first_submitted>
  <results_first_submitted_qc>April 5, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 2, 2012</results_first_posted>
  <last_update_submitted>May 2, 2012</last_update_submitted>
  <last_update_submitted_qc>May 2, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 8, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bone Marrow Transplant</keyword>
  <keyword>Massage</keyword>
  <keyword>Pediatric Oncology</keyword>
  <keyword>children undergoing bone marrow transplantation</keyword>

  <clinical_results>

    <participant_flow>
      <recruitment_details>November 2008-November 2009, 12 months UCSF Children's Hospital, Bone Marrow Transplant Unit</recruitment_details>
      <pre_assignment_details>consecutive enrollment of all eligible admitted children. 2 teenage boys declined participation</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Massage</title>
          <description>massage and acupressure up to 3x/week for entire hospital stay</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>usual care only as control arm hospital care during bone marrow transplant</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Massage</title>
          <description>massage and acupressure up to 3x/week for entire hospital stay</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>usual care only as control arm hospital care during bone marrow transplant</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
            <count group_id="B2" value="7"/>
            <count group_id="B3" value="23"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10.9" spread="3.7"/>
                    <measurement group_id="B2" value="13.7" spread="4.3"/>
                    <measurement group_id="B3" value="11.7" spread="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Days With Pain Scores &gt;3 Measured on Numeric Rating Scale (Range 0-10; 0 for no Pain; 10 for Worst Pain Imaginable)</title>
        <description>days of pain &gt;3 by nurses notes based on pain scores on numeric rating scale (up to 28 days)</description>
        <time_frame>7 days pre to 21 days post transplant = 28 days</time_frame>
        <population>ITT no imputations</population>
        <group_list>
          <group group_id="O1">
            <title>Massage</title>
          </group>
          <group group_id="O2">
            <title>Control</title>
          </group>
        </group_list>
        <measure>
          <title>Number of Days With Pain Scores &gt;3 Measured on Numeric Rating Scale (Range 0-10; 0 for no Pain; 10 for Worst Pain Imaginable)</title>
          <description>days of pain &gt;3 by nurses notes based on pain scores on numeric rating scale (up to 28 days)</description>
          <population>ITT no imputations</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.7" spread="4.9" lower_limit="5.2" upper_limit="10.2"/>
                    <measurement group_id="O2" value="8.3" spread="5.5" lower_limit="2.8" upper_limit="13.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>comparison between groups by t-test</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.80</p_value>
            <p_value_desc>unadjusted</p_value_desc>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.6</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-5.4</ci_lower_limit>
            <ci_upper_limit>4.2</ci_upper_limit>
            <estimate_desc>this was a feasibility pilot study CI is descriptor of dispersion</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Vomiting Episodes</title>
        <description>number of vomiting episodes as reported by nurses per occurence (no upper limit)</description>
        <time_frame>day -7 to +21 around transplant date</time_frame>
        <population>ITT</population>
        <group_list>
          <group group_id="O1">
            <title>Massage</title>
          </group>
          <group group_id="O2">
            <title>Control</title>
          </group>
        </group_list>
        <measure>
          <title>Number of Vomiting Episodes</title>
          <description>number of vomiting episodes as reported by nurses per occurence (no upper limit)</description>
          <population>ITT</population>
          <units>number of episodes</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.6" lower_limit="2.0" upper_limit="7.3"/>
                    <measurement group_id="O2" value="7.0" lower_limit="3.0" upper_limit="11.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.29</p_value>
            <p_value_desc>unadjusted</p_value_desc>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-2.38</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-6.9</ci_lower_limit>
            <ci_upper_limit>2.1</ci_upper_limit>
            <estimate_desc>CI serves as dispersion measure</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Days of Hospital Stay</title>
        <description>days of hospital stay after bone marrow transplant (up to 100 days; participant observation was censored after 100 days)</description>
        <time_frame>days of hospital stay after bone marrow transplant</time_frame>
        <population>ITT</population>
        <group_list>
          <group group_id="O1">
            <title>Massage</title>
          </group>
          <group group_id="O2">
            <title>Control</title>
          </group>
        </group_list>
        <measure>
          <title>Days of Hospital Stay</title>
          <description>days of hospital stay after bone marrow transplant (up to 100 days; participant observation was censored after 100 days)</description>
          <population>ITT</population>
          <units>number of days</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.1" lower_limit="24.8" upper_limit="53.3"/>
                    <measurement group_id="O2" value="35.3" lower_limit="2.1" upper_limit="68.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.78</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>-3.8</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-31.9</ci_lower_limit>
            <ci_upper_limit>24.3</ci_upper_limit>
            <estimate_desc>95% CI is dispersion parameter</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Days to Recovery Neutrophil Count</title>
        <description>number of days to recovery neutrophil count &gt;500 cells per microliter for 2 consecutive days (range, up to 100 days, censored at 100 days)</description>
        <time_frame>hospital stay</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Massage</title>
          </group>
          <group group_id="O2">
            <title>Control</title>
          </group>
        </group_list>
        <measure>
          <title>Days to Recovery Neutrophil Count</title>
          <description>number of days to recovery neutrophil count &gt;500 cells per microliter for 2 consecutive days (range, up to 100 days, censored at 100 days)</description>
          <units>number of days</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.8" spread="14.3" lower_limit="14.3" upper_limit="19.4"/>
                    <measurement group_id="O2" value="18.7" lower_limit="7.3" upper_limit="30.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.70</p_value>
            <method>t-test, 2 sided</method>
            <method_desc>unadjusted</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>5.8</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-9.5</ci_lower_limit>
            <ci_upper_limit>13.2</ci_upper_limit>
            <estimate_desc>95%CI is dispersion measure</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>any adverse events were documented during entire hospital stay, censored at 100 days.</time_frame>
      <desc>Medical records were checked weekly, nurse managers were contacted regularly, attending physicians were ready to inform the research team for any eventual adverse events.</desc>
      <group_list>
        <group group_id="E1">
          <title>Massage</title>
          <description>massage and acupressure up to 3x/week for entire hospital stay</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>usual care only as control arm hospital care during bone marrow transplant</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>small sample size
limited number of time points for self-report assessments.
the dose of the massage intervention averaged 1.8 massages per week, while the target dose was 3 per week.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Wolf Mehling, MD</name_or_title>
      <organization>UCSF</organization>
      <phone>415-353 9506</phone>
      <email>mehlingw@ocim.ucsf.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

